Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04615260Not ApplicableActive Not Recruiting

Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.

Role: lead

NCT06256458Recruiting

Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

Role: lead

NCT04439032Active Not Recruiting

Artoss Prospective Spine Registry Outcomes

Role: lead

NCT04503759Completed

Artoss Foot and Ankle Surgery Registry

Role: lead

All 4 trials loaded